Devices/Recall·openFDA/device

Avanos Medical, Inc. — Class II: Product Name: CORFLO* Safety PEG Kit with ENFit¿ Connector Model/Catalog Number: 50-4320

MediumPublished Jun 17, 2026· AI-analyzed Jun 23, 2026View original FDA source
AI-generated regulatory interpretation. The four sections below are an analyst-style summary produced by an AI model from the original FDA source. Always verify against the source before any regulatory, clinical, or commercial decision.
What happened

Avanos Medical, Inc. has initiated a Class II recall for its CORFLO Safety PEG Kit with ENFit Connector (Model 50-4320) due to the inclusion of Lidocaine hydrochloride injection units that were subject to a supplier-level recall for quality issues.

Who it affects

This recall affects Avanos Medical, Inc., stakeholders managing the CORFLO Safety PEG Kit supply chain, and clinical facilities utilizing these specific sterile kits.

Why it matters

The recall highlights the regulatory risks associated with convenience kits where a single defective component—in this case, an outsourced drug component—compromises the entire sterile set. This suggests a need for robust supplier monitoring systems to ensure that upstream recalls of constituent parts are integrated into the final manufacturer's post-market safety actions.

Practical takeaway

Review incoming component quality agreements and supplier change notifications to ensure external drug recalls are promptly identified. Conduct a reconciliation of inventory for kits containing the specified Lidocaine hydrochloride injection to facilitate quarantine and removal as required.

FDA source material

Class II. Reason: Lidocaine hydrochloride injection, the subject of a supplier recall for quality issues, were included into sterile kits and sets.. Product: Product Name: CORFLO* Safety PEG Kit with ENFit¿ Connector Model/Catalog Number: 50-4320. Firm: Avanos Medical, Inc. (Alpharetta GA United States). Status: Ongoing.

Open in openFDA / FDA.gov
AI-generated interpretation. Always verify critical decisions against the original FDA source. Generated with google/gemini-3-flash-preview.